The p38 MAPK pathway is critical for 5,5′-dibromodiindolylmethane- induced apoptosis to prevent oral squamous carcinoma cells

European Journal of Cancer Prevention

Volumn 19, Issue 2, 2010, Pages 153-159

  Choi, Kyeong Hee ^a   Kim, Hyung Kook ^a   Kim, Jun Hee ^a   Choi, Eun Sun ^a   Shin, Ji Ae ^a   Lee, Syng Ook ^e   Chintharlapalli, Sudhakar ^e   Safe, Stephen ^e   Abdelrahim, Maen ^e   Kong, Gu ^b   Choi, Hong Seok ^c   Jung, Ji Youn ^d   Cho, Hyun Tae ^a   Cho, Nam Pyo ^a   Cho, Sung Dae ^a  

^a Chonbuk National University   (South Korea)

^b Hanyang University   (South Korea)

^c Chosun University   (South Korea)

^d Kongju National University   (South Korea)

^e TEXAS A AND M HEALTH SCIENCE CENTER   (United States)

Author keywords

5,5 dibromodiindolylmethane; Apoptosis; Bcl 2; Human oral squamous carcinoma cells; Mitochondrial membrane potentials; P38 mitogen activated protein kinase

Indexed keywords

5,5' DIBROMODIINDOLYLMETHANE; ANTINEOPLASTIC AGENT; CASPASE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; POLY(ADENOSINE DIPHOSPHATE RIBOSE); PROTEIN BCL 2; STRESS ACTIVATED PROTEIN KINASE; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER GROWTH; CELL CYCLE G1 PHASE; CELL DEATH; CELL NUCLEUS; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME ACTIVATION; FRAGMENTATION REACTION; HUMAN; HUMAN CELL; MITOCHONDRIAL MEMBRANE POTENTIAL; MOUTH CARCINOMA; POLYMERIZATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA;

APOPTOSIS; BLOTTING, WESTERN; CARCINOMA, SQUAMOUS CELL; CELL CYCLE; CELL PROLIFERATION; HUMANS; INDOLES; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MEMBRANE POTENTIAL, MITOCHONDRIAL; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MOUTH NEOPLASMS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PROTO-ONCOGENE PROTEINS C-BCL-2; SIGNAL TRANSDUCTION; TUMOR CELLS, CULTURED;

EID: 76449102161     PISSN: 09598278     EISSN: None     Source Type: Journal    
DOI: 10.1097/CEJ.0b013e328333d088     Document Type: Article

References (31)

1. Aggarwal BB, Ichikawa H (2005). Molecular targets and anticancer potential of indole-3-carbinol and its derivatives. Cell Cycle 4:1201-1215.
2. Broadbent TA, Broadbent HS (1998). The chemistry and pharmacology of indole-3-carbinol (indole-3-methanol) and 3-(methoxymethyl)indole. [Part II]. Curr Med Chem 5:469-491.
3. Butler MS (2004). The role of natural product chemistry in drug discovery. J Nat Prod 67:2141-2153.
4. Chang X, Tou JC, Hong C, Kim HA, Riby JE, Firestone GL, Bjeldanes LF (2005). 3,30-Diindolylmethane inhibits angiogenesis and the growth of transplantable human breast carcinoma in athymic mice. Carcinogenesis 26:771-778.
5. Chen I, McDougal A, Wang F, Safe S (1998). Aryl hydrocarbon receptormediated antiestrogenic and antitumorigenic activity of diindolylmethane. Carcinogenesis 19:1631-1639.
6. Cho SD, Ahn NS, Jung JW, Yang SR, Park JS, Lee YS, et al. (2006). Critical role of the c-JunNH2-terminal kinase and p38 mitogen-activated protein kinase pathways on sodium butyrate-induced apoptosis in DU145 human prostate cancer cells. Eur J Cancer Prev 15:57-63.
7. Cho SD, Chintharlapalli S, Abdelrahim M, Papineni S, Liu S, Guo J, et al. (2008). 5,50-Dibromo-bis(30-indolyl)methane induces Kruppel-like factor 4 and p21 in colon cancer cells. Mol Cancer Ther 7:2109-2120.
8. Gong Y, Sohn H, Xue L, Firestone GL, Bjeldanes LF (2006). 3,30-Diindolylmethane is a novel mitochondrial H( + )-ATP synthase inhibitor that can induce p21(Cip1/Waf1) expression by induction of oxidative stress in human breast cancer cells. Cancer Res 66:4880-4887.
9. Green DR, Reed JC (1998). Mitochondria and apoptosis. Science 281:1309-1312.
10. Grubbs CJ, Steele VE, Casebolt T, Juliana MM, Eto I,Whitaker LM, et al. (1995). Chemoprevention of chemically-induced mammary carcinogenesis by indole-3-carbinol. Anticancer Res 15:709-716.
11. Hengartner MO (2000). The biochemistry of apoptosis. Nature 407:770-776.
12. Jo EH, Kim SH, Ahn NS, Park JS, Hwang JW, Lee YS, Kang KS (2007). Efficacy of sulforaphane is mediated by p38 MAP kinase and caspase-7 activations in ER-positive and COX-2-expressed human breast cancer cells. Eur J Cancer Prev 16:505-510.
13. Kikuchi M, Tenneti L, Lipton SA (2000). Role of p38 mitogen-activated protein kinase in axotomy-induced apoptosis of rat retinal ganglion cells. J Neurosci 20:5037-5044.
14. Kim BM, Chung HW (2008). Desferrioxamine (DFX) induces apoptosis through the p38-caspase8-Bid-Bax pathway in PHA-stimulated human lymphocytes. Toxicol Appl Pharmacol 228:24-31.
15. Kluck RM, Bossy-Wetzel E, Green DR, Newmeyer DD (1997). The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis. Science 275:1132-1136.
16. Koehn FE, Carter GT (2005). The evolving role of natural products in drug discovery. Nat Rev Drug Discov 4:206-220.
17. Lee SH, Kim JS, Yamaguchi K, Eling TE, Baek SJ (2005). Indole-3-carbinol and 3,30-diindolylmethane induce expression of NAG-1 in a p53-independent manner. Biochem Biophys Res Commun 328:63-69.
18. McDougal A, Sethi Gupta M, Ramamoorthy K, Sun G, Safe SH (2000). Inhibition of carcinogen-induced rat mammary tumor growth and other estrogen-dependent responses by symmetrical dihalo-substituted analogs of diindolylmethane. Cancer Lett 151:169-179.
19. McDougal A, Gupta MS, Morrow D, Ramamoorthy K, Lee JE, Safe SH (2001). Methyl-substituted diindolylmethanes as inhibitors of estrogen-induced growth of T47D cells and mammary tumors in rats. Breast Cancer Res Treat 66:147-157.
20. Nachshon-Kedmi M, Yannai S, Haj A, Fares FA (2003). Indole-3-carbinol and 3,30 -diindolylmethane induce apoptosis in human prostate cancer cells. Food Chem Toxicol 41:745-752.
21. Nachshon-Kedmi M, Yannai S, Fares FA (2004). Induction of apoptosis in human prostate cancer cell line, PC3, by 3,30-diindolylmethane through the mitochondrial pathway. Br J Cancer 91:1358-1363.
22. Newman DJ, Cragg GM, Snader KM (2003). Natural products as sources of new drugs over the period 1981-2002. J Nat Prod 66:1022-1037.
23. Preobrazhenskaya MN, Bukhman VM, Korolev AM, Efimov SA (1993). Ascorbigen and other indole-derived compounds from Brassica vegetables and their analogs as anticarcinogenic and immunomodulating agents. Pharmacol Ther 60:301-313.
24. Rahman KM, Aranha O, Sarkar FH (2003). Indole-3-carbinol (I3C) induces apoptosis in tumorigenic but not in nontumorigenic breast epithelial cells. Nutr Cancer 45:101-112.
25. Rahman KM, Li Y, Sarkar FH (2004). Inactivation of akt and NF-kappaB play important roles during indole-3-carbinol-induced apoptosis in breast cancer cells. Nutr Cancer 48:84-94.
26. Reddy KB, Nabha SM, Atanaskova N (2003). Role of MAP kinase in tumor progression and invasion. Cancer Metastasis Rev 22:395-403.
27. Tikhomirov O, Carpenter G (2004). Ligand-induced, p38-dependent apoptosis in cells expressing high levels of epidermal growth factor receptor and ErbB-2. J Biol Chem 279:12988-12996.
28. Vanderlaag K, Samudio I, Burghardt R, Barhoumi R, Safe S (2006). Inhibition of breast cancer cell growth and induction of cell death by 1,1-bis(30-indolyl)methane (DIM) and 5,50-dibromoDIM. Cancer Lett 236:198-212.
29. Verhoeven DT, Verhagen H, Goldbohm RA, van den Brandt PA, van Poppel G (1997). A review of mechanisms underlying anticarcinogenicity by brassica vegetables. Chem Biol Interact 103:79-129.
30. Xue L, Firestone GL, Bjeldanes LF (2005). DIM stimulates IFNgamma gene expression in human breast cancer cells via the specific activation of JNK and p38 pathways. Oncogene 24:2343-2353.
31. Yang J, Liu X, Bhalla K, Kim CN, Ibrado AM, Cai J, et al. (1997). Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked. Science 275:1129-1132.